These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 29203394)

  • 1. Percutaneous Microwave versus Radiofrequency Ablation of Colorectal Liver Metastases: Ablation with Clear Margins (A0) Provides the Best Local Tumor Control.
    Shady W; Petre EN; Do KG; Gonen M; Yarmohammadi H; Brown KT; Kemeny NE; D'Angelica M; Kingham PT; Solomon SB; Sofocleous CT
    J Vasc Interv Radiol; 2018 Feb; 29(2):268-275.e1. PubMed ID: 29203394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal Cancer Liver Metastases: Biopsy of the Ablation Zone and Margins Can Be Used to Predict Oncologic Outcome.
    Sotirchos VS; Petrovic LM; Gönen M; Klimstra DS; Do RK; Petre EN; Garcia AR; Barlas A; Erinjeri JP; Brown KT; Covey AM; Alago W; Brody LA; DeMatteo RP; Kemeny NE; Solomon SB; Manova-Todorova KO; Sofocleous CT
    Radiology; 2016 Sep; 280(3):949-59. PubMed ID: 27010254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases.
    Odisio BC; Yamashita S; Huang SY; Kopetz SE; Ahrar K; Mizuno T; Conrad C; Aloia TA; Chun YS; Gupta S; Vauthey JN
    J Vasc Interv Radiol; 2018 Mar; 29(3):395-403.e1. PubMed ID: 29395898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.
    Shady W; Petre EN; Gonen M; Erinjeri JP; Brown KT; Covey AM; Alago W; Durack JC; Maybody M; Brody LA; Siegelbaum RH; D'Angelica MI; Jarnagin WR; Solomon SB; Kemeny NE; Sofocleous CT
    Radiology; 2016 Feb; 278(2):601-11. PubMed ID: 26267832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter CT Hepatic Arteriography Compared with Conventional CT Fluoroscopy Guidance in Percutaneous Thermal Ablation to Treat Colorectal Liver Metastases: A Single-Center Comparative Analysis of 2 Historical Cohorts.
    Puijk RS; Nieuwenhuizen S; van den Bemd BAT; Ruarus AH; Geboers B; Vroomen LGPH; Muglia R; de Jong MC; de Vries JJJ; Scheffer HJ; van den Tol PMP; Meijerink MR
    J Vasc Interv Radiol; 2020 Nov; 31(11):1772-1783. PubMed ID: 32981819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microwave Ablation in the Management of Colorectal Cancer Pulmonary Metastases.
    Kurilova I; Gonzalez-Aguirre A; Beets-Tan RG; Erinjeri J; Petre EN; Gonen M; Bains M; Kemeny NE; Solomon SB; Sofocleous CT
    Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1530-1544. PubMed ID: 29845348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.
    De Cobelli F; Calandri M; Della Corte A; Sirovich R; Gazzera C; Della Vigna P; Bonomo G; Varano GM; Maiettini D; Mauri G; Camisassi N; Steidler S; Ratti F; Gusmini S; Ronzoni M; Aldrighetti L; Odisio BC; Racca P; Fonio P; Veltri A; Orsi F
    Eur Radiol; 2022 Jun; 32(6):4147-4159. PubMed ID: 35092474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave versus Radiofrequency Ablation Treatment for Hepatocellular Carcinoma: A Comparison of Efficacy at a Single Center.
    Potretzke TA; Ziemlewicz TJ; Hinshaw JL; Lubner MG; Wells SA; Brace CL; Agarwal P; Lee FT
    J Vasc Interv Radiol; 2016 May; 27(5):631-8. PubMed ID: 27017124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival.
    Calandri M; Yamashita S; Gazzera C; Fonio P; Veltri A; Bustreo S; Sheth RA; Yevich SM; Vauthey JN; Odisio BC
    Eur Radiol; 2018 Jul; 28(7):2727-2734. PubMed ID: 29417253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.
    Lorentzen T; Skjoldbye BO; Nolsoe CP
    Ultraschall Med; 2011 Oct; 32(5):492-6. PubMed ID: 21259183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can tumor coverage evaluated 24 h post-radiofrequency ablation predict local tumor progression of liver metastases?
    Vandenbroucke F; Vandemeulebroucke J; Buls N; Thoeni RF; de Mey J
    Int J Comput Assist Radiol Surg; 2018 Dec; 13(12):1981-1989. PubMed ID: 29651715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propofol Compared to Midazolam Sedation and to General Anesthesia for Percutaneous Microwave Ablation in Patients with Hepatic Malignancies: A Single-Center Comparative Analysis of Three Historical Cohorts.
    Puijk RS; Ziedses des Plantes V; Nieuwenhuizen S; Ruarus AH; Vroomen LGPH; de Jong MC; Geboers B; Hoedemaker-Boon CJ; Thöne-Passchier DH; Gerçek CC; de Vries JJJ; van den Tol PMP; Scheffer HJ; Meijerink MR
    Cardiovasc Intervent Radiol; 2019 Nov; 42(11):1597-1608. PubMed ID: 31243542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated With Local Tumor Control and Complications After Thermal Ablation of Colorectal Cancer Liver Metastases: A 15-year Retrospective Cohort Study.
    Kurilova I; Bendet A; Petre EN; Boas FE; Kaye E; Gonen M; Covey A; Brody LA; Brown KT; Kemeny NE; Yarmohammadi H; Ziv E; D'Angelica MI; Kingham TP; Cercek A; Solomon SB; Beets-Tan RGH; Sofocleous CT
    Clin Colorectal Cancer; 2021 Jun; 20(2):e82-e95. PubMed ID: 33246789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression.
    Kaye EA; Cornelis FH; Petre EN; Tyagi N; Shady W; Shi W; Zhang Z; Solomon SB; Sofocleous CT; Durack JC
    Eur Radiol; 2019 May; 29(5):2698-2705. PubMed ID: 30402706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
    Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
    Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local tumor progression after radiofrequency ablation of colorectal liver metastases: evaluation of ablative margin and three-dimensional volumetric analysis.
    Frich L; Hagen G; Brabrand K; Edwin B; Mathisen O; Aaløkken TM; Gladhaug IP
    J Vasc Interv Radiol; 2007 Sep; 18(9):1134-40. PubMed ID: 17804776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy.
    Sofocleous CT; Petre EN; Gonen M; Brown KT; Solomon SB; Covey AM; Alago W; Brody LA; Thornton RH; D'Angelica M; Fong Y; Kemeny NE
    J Vasc Interv Radiol; 2011 Jun; 22(6):755-61. PubMed ID: 21514841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
    Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
    Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous ultrasound guided radiofrequency and microwave ablation in the treatment of hepatic metastases. A monocentric initial experience.
    Sparchez Z; Mocan T; Hajjar NA; Bartos A; Hagiu C; Matei D; Craciun R; Mocan LP; Sparchez M; Leucuta DC
    Med Ultrason; 2019 Aug; 21(3):217-224. PubMed ID: 31476199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.